TurnerTrends Stock Rating Report for ANSV
Data valid for week beginning July 21, 2008
|
ANSV [News]
|
Anesiva Inc
|
Company Profile
"Anesiva, Inc., a biopharmaceutical company, engages in the development and commercialization of novel therapeutic treatments for pain management. Its portfolio of products includes Zingo, which is approved for use in children 3 to 18 years of age for the reduction of pain associated with venipunctures- and Adlea, a Phase 2 trials completed product for post-surgical, musculoskeletal, and neuropathic pain. The company was founded in 2001 and is headquartered in South San Francisco, California."
|
Join today to see our Technical, Fundamental, and Composite Stock Rating for this stock.
|
|
|
Want to take a more "hands off" approach to investing with TurnerTrends? Try our managed accounts and hedge fund at Sabinal Capital Investments
|
|
Latest News
| Thu, 17 Jul 2008 11:00:00 Etc/GMT | Anesiva Commences Phase 2 Trial of Adlea(TM) in Arthroscopic Shoulder Surgery (PR Newswire) | | Thu, 3 Jul 2008 20:45:09 Etc/GMT | Anesiva VP to leave company (at bizjournals.com) | | Thu, 3 Jul 2008 20:07:12 Etc/GMT | ANESIVA, INC. Files SEC form 8-K, Change in Directors or Principal Officers (EDGAR Online) | | Tue, 1 Jul 2008 16:59:14 Etc/GMT | Anesiva Still at a Great Value (Zacks.com) | | Mon, 30 Jun 2008 12:17:04 Etc/GMT | Anesiva launches Zingo topical anesthetic for kids (AP) | | Mon, 30 Jun 2008 11:00:00 Etc/GMT | Anesiva Launches Needle-Free Zingo(TM) to Reduce Pain from IV Starts and Blood Draws in Children (PR Newswire) | | Thu, 26 Jun 2008 22:15:08 Etc/GMT | GE Capital extends loan deal with Anesiva, waives default (at bizjournals.com) | | Thu, 26 Jun 2008 20:15:27 Etc/GMT | ANESIVA, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and Exhibits (EDGAR Online) | | Thu, 19 Jun 2008 20:15:51 Etc/GMT | ANESIVA, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (EDGAR Online) | | Thu, 19 Jun 2008 00:00:00 Etc/GMT | Annual Report for Anesiva Inc. (WILink) | | Mon, 16 Jun 2008 21:50:35 Etc/GMT | Anesiva names Michael L. Kranda as new CEO (AP) | | Mon, 16 Jun 2008 20:35:23 Etc/GMT | Anesiva names Michael Kranda CEO (at bizjournals.com) | | Mon, 16 Jun 2008 14:39:00 Etc/GMT | Anesiva Names Michael L. Kranda as President, Chief Executive Officer and Member of Its Board of Directors (PR Newswire) | | Thu, 5 Jun 2008 11:00:00 Etc/GMT | Anesiva and Transcription Factor Therapeutics, Inc. Announce Licensing Agreement for Development and Commercialization of NF-kappa B Clinical Program (PR Newswire) | | Wed, 4 Jun 2008 11:00:00 Etc/GMT | Anesiva Announces June 11, 2008 Presentation at Needham 7th Annual Biotechnology & Medical Technology Conference (PR Newswire) | | Tue, 3 Jun 2008 11:00:00 Etc/GMT | Anesiva Announces South Korea FDA Approval of Adlea(TM) Investigational New Drug Application (PR Newswire) | | Wed, 21 May 2008 11:00:00 Etc/GMT | FDA Accepts Zingo(TM) Supplemental New Drug Application to Reduce Pain Associated With Peripheral Needle Insertion Procedures in Adults (PR Newswire) | | Fri, 16 May 2008 11:00:00 Etc/GMT | Anesiva Announces May 22, 2008 Presentation at Citi Investment Research Global HealthCare Conference (PR Newswire) | | Wed, 14 May 2008 13:04:39 Etc/GMT | ANESIVA, INC. Financials (EDGAR Online Financials) | | Sun, 11 May 2008 13:33:13 Etc/GMT | New Star Analyst Rankings for ANESIVA INC (StarMine) | News provided by Yahoo! Finance |
|
